OPKO Health, Inc. (0KCS.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 06:00PM BST
| Previous close | 2.9800 |
| Open | 3.0800 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 3.0000 - 3.0850 |
| 52-week range | 3.0000 - 3.0850 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 1.422B |
| Beta (5Y monthly) | 1.86 |
| PE ratio (TTM) | 25.42 |
| EPS (TTM) | 0.1180 |
| Earnings date | 26 Apr 2022 - 02 May 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
OPKO Health (OPK) Post In-Line Q1 Earnings, Revenues Top
OPKO Health's (OPK) first-quarter results benefit from continued strength in its Pharmaceuticals segment.
- Motley Fool
Why Opko Health Stock Is Jumping Today
Shares of Opko Health (NASDAQ: OPK) were jumping 13.5% higher as of 12:31 p.m. ET on Tuesday. Opko also announced on Monday that it has acquired ModeX Therapeutics in an all-stock deal valued at $300 million. The acquisition of ModeX could be good for Opko over the long term.
- Motley Fool
Opko Health (OPK) Q1 2022 Earnings Call Transcript
This is Yvonne Briggs with LHA. Thank you all for joining today's call to discuss OPKO Health's financial results for the first quarter of 2022, as well as the recently announced ModeX Therapeutics acquisition.
© 2022 Yahoo. All rights reserved.
